Programmed death ligand 1 (PD-L1) expression in gastric cancer: literature review
Gastric cancer is one of the most common oncological diseases at the present time, so research in this area is very significant and relevant. Immunological checkpoint inhibitors have previously demonstrated their effectiveness and safety in various solid tumors, however, with regard to stomach canc...
Saved in:
Main Authors: | T. N. Sotnikova, N. V. Danilova, P. G. Malkov, T. V. Polushkina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2023-07-01
|
Series: | Успехи молекулярной онкологии |
Subjects: | |
Online Access: | https://umo.abvpress.ru/jour/article/view/542 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Programmed death‐ligand 1 expression in gastric cancer: correlation with mismatch repair deficiency and HER2‐negative status
by: Lei Wang, et al.
Published: (2018-06-01) -
Programmed cell death-ligand 1 expression in correlation with human papillomavirus status in cervical cancer: A 1-year retrospective study
by: Kaumudi Konkay, et al.
Published: (2025-01-01) -
PD-L1 expression predicts the efficacy of PD-1 blockade plus chemotherapy versus chemotherapy alone in treatment-naïve advanced or metastatic gastric cancer: a pooled analysis of reconstructed individual patient-level data from two randomized trials
by: Wei Zhou, et al.
Published: (2025-07-01) -
Transcriptional, growth factors, components of the AKT/mTOR signaling pathway, receptors and ligands of programmed cell death expression in melanoma
by: K. V. Nikulnikov, et al.
Published: (2024-04-01) -
Cancer cell membrane cloaking nanoparticles for targeted co-delivery of doxorubicin and PD-L1 siRNA
by: Mushi Chen, et al.
Published: (2019-12-01)